In this issue of Clinics in Chest Medicine, Guest Editors Harold R Collard, Luca Richeldi, and Kerri A. Johannson bring their considerable expertise to the topic of Next-generation Interstitial Lung Disease.
1. Cover image - p. i 2. Title page - p. i 3. Table of Contents - p. i 4. Copyright - p. ii 5. Contributors - p. iii 6. Forthcoming Issues - p. xi 7. Preface - p. xiii 8. Interstitial Lung Disease in 2020: A History of Progress - p. 229 9. Clinical Relevance and Management of “Pre–Interstitial Lung Disease” - p. 241 10. Diagnostic Classification of Interstitial Lung Disease in Clinical Practice - p. 251 11. Rethinking Idiopathic Pulmonary Fibrosis - p. 263 12. Management of Idiopathic Pulmonary Fibrosis - p. 275 13. Clinical Trials for Idiopathic Pulmonary Fibrosis and the Role of Health Systems - p. 287 14. Management of Connective Tissue Disease-Associated Interstitial Lung Disease - p. 295 15. Management of Fibrotic Hypersensitivity Pneumonitis - p. 311 16. Diagnosis and Management of Fibrotic Interstitial Lung Diseases - p. 321 17. Providing Patient-Centered Care in Interstitial Lung Disease - p. 337 18. Care Delivery Models and Interstitial Lung Disease: The Role of the Specialized Center - p. 347 19. Molecular Markers and the Promise of Precision Medicine for Interstitial Lung Disease - p. 357 20. Regenerative Medicine and the Hope for a Cure - p. 365 21. Looking Ahead: Interstitial Lung Disease Diagnosis and Management in 2030 - p. 375
In this issue of Clinics in Chest Medicine, Guest Editors Harold R Collard, Luca Richeldi, and Kerri A. Johannson bring their considerable expertise to the topic of Next-generation Interstitial Lung Disease.
1. Cover image - p. i 2. Title page - p. i 3. Table of Contents - p. i 4. Copyright - p. ii 5. Contributors - p. iii 6. Forthcoming Issues - p. xi 7. Preface - p. xiii 8. Interstitial Lung Disease in 2020: A History of Progress - p. 229 9. Clinical Relevance and Management of “Pre–Interstitial Lung Disease” - p. 241 10. Diagnostic Classification of Interstitial Lung Disease in Clinical Practice - p. 251 11. Rethinking Idiopathic Pulmonary Fibrosis - p. 263 12. Management of Idiopathic Pulmonary Fibrosis - p. 275 13. Clinical Trials for Idiopathic Pulmonary Fibrosis and the Role of Health Systems - p. 287 14. Management of Connective Tissue Disease-Associated Interstitial Lung Disease - p. 295 15. Management of Fibrotic Hypersensitivity Pneumonitis - p. 311 16. Diagnosis and Management of Fibrotic Interstitial Lung Diseases - p. 321 17. Providing Patient-Centered Care in Interstitial Lung Disease - p. 337 18. Care Delivery Models and Interstitial Lung Disease: The Role of the Specialized Center - p. 347 19. Molecular Markers and the Promise of Precision Medicine for Interstitial Lung Disease - p. 357 20. Regenerative Medicine and the Hope for a Cure - p. 365 21. Looking Ahead: Interstitial Lung Disease Diagnosis and Management in 2030 - p. 375
